Update Alert 3: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
作者信息
Mackey Katherine, Kansagara Devan, Vela Kathryn
机构信息
VA Portland Health Care System, Portland, Oregon (K.M., D.K., K.V.).
出版信息
Ann Intern Med. 2020 Oct 6;173(7):130-131. doi: 10.7326/L20-1068. Epub 2020 Aug 26.
Abstract
摘要
相似文献
1
Update Alert 3: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.更新警报3：成人中血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂对严重急性呼吸综合征冠状病毒2感染的风险及影响
Ann Intern Med. 2020 Oct 6;173(7):130-131. doi: 10.7326/L20-1068. Epub 2020 Aug 26.
2
Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.最新警报2：成人中血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂对严重急性呼吸综合征冠状病毒2感染的风险及影响
Ann Intern Med. 2020 Sep 1;173(5):W87. doi: 10.7326/L20-0969. Epub 2020 Jul 23.
3
Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.最新警报：成人中血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂对严重急性呼吸综合征冠状病毒2感染的风险及影响
Ann Intern Med. 2020 Aug 4;173(3):W66. doi: 10.7326/L20-0887. Epub 2020 Jun 25.
4
Update Alert 4: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.最新警报4：成人中血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂对新型冠状病毒感染的风险及影响
Ann Intern Med. 2020 Nov 3;173(9):W147-W148. doi: 10.7326/L20-1177. Epub 2020 Sep 22.
5
Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.血管紧张素转换酶2与炎症消退：支持继续使用处方血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂
Mayo Clin Proc. 2020 Jul;95(7):1552-1553. doi: 10.1016/j.mayocp.2020.05.001. Epub 2020 May 21.
6
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.血管紧张素转换酶（ACE）抑制剂与血管紧张素II受体阻滞剂对2019冠状病毒病死亡风险的比较影响
Hypertension. 2020 Aug;76(2):e15-e17. doi: 10.1161/HYPERTENSIONAHA.120.15622. Epub 2020 Jun 3.
7
Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus.血管紧张素转换酶抑制剂、血管紧张素 II 受体阻滞剂与冠状病毒
J Hypertens. 2020 Jun;38(6):1190-1191. doi: 10.1097/HJH.0000000000002469.
8
Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.假说：血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂可能会增加 COVID-19 重症风险。
J Travel Med. 2020 May 18;27(3). doi: 10.1093/jtm/taaa041.
9
COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy.COVID-19 与血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂治疗。
Ann Intern Med. 2020 Aug 4;173(3):237-238. doi: 10.7326/M20-3047. Epub 2020 May 15.
10
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.2019冠状病毒病（COVID-19）与心血管疾病：关于血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂对严重急性呼吸综合征冠状病毒2感染的发病和严重程度潜在影响的观点
J Am Heart Assoc. 2020 Apr 7;9(7):e016219. doi: 10.1161/JAHA.120.016219. Epub 2020 Apr 1.
引用本文的文献
1
Past, present and future of living systematic review: a bibliometrics analysis.生命系统综述的过去、现在和未来：文献计量学分析。
BMJ Glob Health. 2022 Oct;7(10). doi: 10.1136/bmjgh-2022-009378.
本文引用的文献
1
Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome.高血压合并 COVID-19 患者住院期间持续使用血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂与临床结局改善相关。
J Infect Dis. 2020 Sep 14;222(8):1256-1264. doi: 10.1093/infdis/jiaa447.
2
Efficacy of ACEIs/ARBs vs CCBs on the progression of COVID-19 patients with hypertension in Wuhan: A hospital-based retrospective cohort study.血管紧张素转换酶抑制剂（ACEI）/血管紧张素Ⅱ受体拮抗剂（ARB）与钙通道阻滞剂（CCB）对武汉高血压合并 COVID-19 患者进展的疗效：一项基于医院的回顾性队列研究。
J Med Virol. 2021 Feb;93(2):854-862. doi: 10.1002/jmv.26315. Epub 2020 Oct 5.
3
COVID-19, ACEI/ARBs, and Gastrointestinal Symptoms: The Jury Is Still Out on the Association.新型冠状病毒肺炎、血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂与胃肠道症状：关于二者之间的关联尚无定论。
Gastroenterology. 2021 Apr;160(5):1896-1897. doi: 10.1053/j.gastro.2020.06.095. Epub 2020 Jul 16.
4
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents.血管紧张素受体阻滞剂（ARBs）、血管紧张素转换酶抑制剂（ACEis）和他汀类药物对养老院居民 COVID-19 感染临床结局的影响。
J Am Med Dir Assoc. 2020 Jul;21(7):909-914.e2. doi: 10.1016/j.jamda.2020.06.018. Epub 2020 Jun 15.
5
Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors.使用肾素-血管紧张素-醛固酮系统抑制剂治疗的高血压患者发生严重 COVID-19 的风险。
Med Clin (Barc). 2020 Dec 11;155(11):488-490. doi: 10.1016/j.medcli.2020.06.013. Epub 2020 Jun 25.
6
Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy.抗高血压药物治疗会影响 COVID-19 感染的高血压患者的临床预后吗？来自意大利南部中心的数据。
J Am Heart Assoc. 2020 Sep;9(17):e016948. doi: 10.1161/JAHA.120.016948. Epub 2020 Jul 7.
7
Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.新冠病毒病患者长期使用血管紧张素转换酶抑制剂与重症疾病几率降低之间的关联。
Anatol J Cardiol. 2020 Jul;24(1):21-29. doi: 10.14744/AnatolJCardiol.2020.57431.
8
Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France.长期使用 ACEI/ARB 与法国东北部转诊中心队列中重症 COVID-19 患者的严重肾功能障碍和急性肾损伤相关。
Clin Infect Dis. 2020 Dec 3;71(9):2447-2456. doi: 10.1093/cid/ciaa677.
9
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis.在 COVID-19 疫情背景下使用血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂：回顾性分析。
Front Med. 2020 Oct;14(5):601-612. doi: 10.1007/s11684-020-0800-y. Epub 2020 Jul 3.
10
Mortality in COVID-19 patients treated with ACEIs/ARBs: Re-estimated meta-analysis results following the Mehra et al. retraction.使用ACEIs/ARBs治疗的COVID-19患者的死亡率：在Mehra等人撤回研究后重新估计的荟萃分析结果。
Pharmacol Res. 2020 Oct;160:105053. doi: 10.1016/j.phrs.2020.105053. Epub 2020 Jun 30.
Zotero 插件